Wantai Biotechnology's announcement on the resignation of the board secretary
Securities code: 603392 Securities abbreviation: Wantai Biotechnology Announcement number: 2026-010
Beijing Wantai Biopharmaceutical Co., Ltd.
Announcement on the resignation of the Board Secretary
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
The board of directors of Beijing Wantai Biopharmaceutical Co., Ltd. (hereinafter referred to as the "Company") recently received a written resignation report submitted by Mr. Yu Tao, secretary of the company's board of directors. Mr. Yu Tao applied to resign as secretary of the company's board of directors due to personal family reasons. After his resignation, he will no longer hold any position in the company. According to the "Company Law of the People's Republic of China", the Articles of Association and relevant regulations, the resignation report will take effect from the date it is delivered to the board of directors.
1. Basic circumstances of resignation
Do you want to continue on? Is there any unused
Original term
Name Resignation position Time of resignation Reason for resignation Municipal company and its controlled Expiry date for completion of performance
Public commitments for holding positions in shareholding companies
March 2026 April 2027 Individual and family
Yu Tao Secretary of the Board of Directors No No 25th 18th Reason
2. The impact of resignation on the company
As of the disclosure date of this announcement, Mr. Yu Tao directly holds 369,130 shares of the company. The management of share changes after his resignation will strictly abide by the relevant provisions of laws, regulations, departmental rules and normative documents such as the "Management Rules for the Company's Shares Held by Directors and Senior Managers of Listed Companies and their Changes", "Interim Measures for the Management of Share Reductions by Shareholders of Listed Companies", "Shanghai Stock Exchange Self-Discipline Supervision Guidelines for Listed Companies No. 15 - Reduction of Shares by Shareholders, Directors and Senior Managers" after his resignation.
Mr. Yu Tao confirmed that he had no differences of opinion with the company's board of directors, that there were no matters related to his resignation that needed to be notified to the company's shareholders, and that the handover work had been completed in accordance with the company's relevant regulations. Mr. Yu Tao's resignation will not affect the normal progress of the company's relevant work. From the date of disclosure of this announcement, the company's board secretary duties will be temporarily performed by Mr. Lu Yun, the company's director and chief financial officer. The company will, in accordance with relevant regulations, complete the selection and appointment of the board secretary as soon as possible and fulfill its information disclosure obligations in a timely manner.
During his tenure as secretary of the company's board of directors, Mr. Yu Tao performed his duties diligently and diligently, and played an active role in corporate governance, information disclosure and investor relations management. The company and its board of directors would like to express our sincere gratitude to Mr. Yu Tao for his contribution to the development of the company!
Announcement is hereby made.
Board of Directors of Beijing Wantai Biopharmaceutical Co., Ltd.
March 26, 2026